GDH Hyperinsulinism (HI/HA Syndrome)
What is GDH hyperinsulinism (HI/HA syndrome)?
Congenital hyperinsulinism (HI) is a genetic disorder in which the insulin cells of the pancreas, called beta cells, secrete too much insulin. Excess insulin causes low blood sugar (hypoglycemia).
Ordinarily, beta cells secrete just enough insulin to keep the blood sugar in the normal range. In children with HI, the secretion of insulin is not properly regulated, causing excess insulin secretion and low blood sugar.
In GDH-HI, excess insulin secretion causes low blood glucose with fasting, or when the child eats protein.
Causes of GDH-HI
GDH-HI is caused by a defective GDH gene (glutamate dehydrogenase). 70 percent of mutations are de novo, meaning the genetic alteration is present for the first time in one family. Otherwise this form of HI is cause by a dominant inheritance, meaning a child needs to inherit only one mutated GDH gene from a parent to develop the disease.
Symptoms of GHD-HI
Children with GDH-HI often present with hyperammonemia, which is elevated concentration of ammonia in the blood.
Congenital hyperinsulinism also causes low blood sugar (hypoglycemia).The symptoms of hypoglycemia in infants are often difficult to identify, as they can be similar to normal infant activities.
Common symptoms of hypoglycemia include:
- excessive hunger
- rapid heart rate
More severe symptoms, such as seizures and coma, can occur with a prolonged low blood sugar or an extremely low blood sugar. Common symptoms of hypoglycemia in older children include feelings of shakiness, weakness, tiredness, confusion, and rapid heart rate.
We consider a normal blood sugar to be >70 mg/dL. Anything less than 60 mg/dL is low, although severe symptoms due to hypoglycemia are not likely unless the blood sugar is less than 50 mg/dL. Prolonged or severe low blood sugar can cause seizures and permanent brain damage.
Diagnosis of GDH-HI
The diagnosis of congenital hyperinsulinism is based on history, laboratory findings, and genetic testing. Prompt diagnosis and establishment of effective treatment are essential to avoid neurologic damage. The diagnosis is made by evaluating the child's medical history, and the result of laboratory and genetic tests.
The history of the child is an important piece of the puzzle. This includes information such as when the low blood sugars started, the timing of the low blood sugars, whether the baby was born large for gestational age (LGA), any family history of low blood sugar or unexplained infant deaths.
Blood tests drawn when the blood sugar is less than 50 mg/dL are essential to the diagnosis of HI. In congenital HI, with a blood sugar <50, you will see suppressed ketones and free fatty acids, an elevated insulin level (although this may not always be captured), and a glycemic response to glucagon, with the blood sugar rising more than 30 mg/dL when glucagon is administered.
It is important that these samples at the time of a critically low blood sugar be obtained in an experienced, controlled environment, as we do not want a child to be kept with a critically low blood sugar longer than is absolutely necessary to make the diagnosis.
The DNA from a blood sample from the child with congenital HI and each parent can be analyzed to screen for the mutations that cause the most common types of HI. This can be done at commercial laboratories and should be considered in any child suspected to have congenital HI. Contact us for more information on where to have this testing performed.
Protein tolerance test
An oral protein tolerance test can also be useful in diagnosing GDH-HI, as a protein load can trigger high insulin levels and low blood glucose. The Children’s Hospital of Philadelphia has special expertise in protein tolerance testing.
Treatment for GDH-HI
GDH-HI is very well controlled with a medicine called diazoxide (Proglycem).
We are now tracking and compiling data on the long-term outlook for children with Congenital HI. We know that with rapid diagnosis and appropriate treatment, keeping blood sugars >70 mg/dL, it is less likely that children with congenital HI will have long-term effects of hypoglycemia. With focal hyperinsulinism, 94 percent of children are cured with surgery.